Document is current
Any future updates will be listed below
-
Authors
Meyer, Jaimie P. https://orcid.org/0000-0001-5735-385X
Price, Carolina R.
Ye, Yiwen
Qin, Yilu
Tracey, DeShana
Demidont, A. C.
Melbourne, Kathleen
Altice, Frederick L.
-
Funding
Funding for this research was provided by:
Gilead Sciences (Gilead Sciences)
- License Information
-
More Information
Article History
Accepted: 5 May 2022
First Online: 7 June 2022
Declarations
:
: Jaimie Meyer: research support from Gilead Sciences. Rick Altice: research support from Merck; consulting for Abbvie, Gilead. A.C. Demidont and Kathleen Melbourne are employees of Gilead Sciences and own stock in Gilead Sciences.
: All procedures were approved by the Yale University Human Investigations Committee, research advisory committees at the Connecticut Department of Corrections (DOC) and Judicial Branch Court Support Services Division of Adult Probation (CSSD), and the Operations Management Team at a partnering community drug treatment agency.
: All enrolled participants provided written informed consent to participate.
: Not applicable.
